Literature DB >> 12840920

Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma.

W Yang1, X Zeng, C Chen, Z Chen, G Du.   

Abstract

In order to elucidate the mechanisms of multidrug resistance (MDR) in bladder cancer, the expression of glutathione S-transferase-pi (GST-pi) and multidrug resistance associated protein (MRP) in tissue samples resected from 44 patients and 6 normal bladder mucosa as control was detected by using immunohistochemical method, and the results were analyzed by computer-assisted image analyzing system (IAS) to achieve semi-quantitative data. In addition, correlation between the expression of both factors was studied. The results showed that the positive expression rate of GST-pi and MRP in bladder cancer was 72.7% (32/44) and 68.2% (30/44) respectively, significantly higher than those in normal bladder mucosa, being 16.7% and 33.3% respectively. The rate of GST-pi positive staining was increased correspondingly with tumor grade and stage elevated, being higher in recurrent tumors treated by chemotherapy, but not significantly (P > 0.05). There was no significant differences between the expression of MRP and tumors' behaviors and clinical characters. However, the results demonstrated that the correlation between the expression of both resistant factors was very evident (r = 0.695, P < 0.0025). It was suggested that the activation of GST-pi and MRP might occur during malignant transformation of normal mucosa, but tumors' differentiation and progression could not be the unique factors that influenced both overexpression. Chemotherapy might be another important reason. The correlation of both indicated that there was a common mechanism regulating their expression probably, which made them play a pivotal role in chemotherapy drug resistance of bladder cancers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12840920     DOI: 10.1007/bf02888188

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  14 in total

Review 1.  The ATP-dependent glutathione S-conjugate export pump.

Authors:  T Ishikawa
Journal:  Trends Biochem Sci       Date:  1992-11       Impact factor: 13.807

Review 2.  The biochemistry of P-glycoprotein-mediated multidrug resistance.

Authors:  J A Endicott; V Ling
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 3.  Importance of glutathione and associated enzymes in drug response.

Authors:  H Shen; L Kauvar; K D Tew
Journal:  Oncol Res       Date:  1997       Impact factor: 5.574

4.  Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.

Authors:  K D Tew; A Monks; L Barone; D Rosser; G Akerman; J A Montali; J B Wheatley; D E Schmidt
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

5.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.

Authors:  I Leier; G Jedlitschky; U Buchholz; S P Cole; R G Deeley; D Keppler
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

6.  Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Authors:  G J Zaman; J Lankelma; O van Tellingen; J Beijnen; H Dekker; C Paulusma; R P Oude Elferink; F Baas; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.

Authors:  S Kotoh; S Naito; A Yokomizo; J Kumazawa; K Asakuno; K Kohno; M Kuwano
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

8.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

Authors:  C E Grant; G Valdimarsson; D R Hipfner; K C Almquist; S P Cole; R G Deeley
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

Review 9.  Glutathione-associated enzymes in anticancer drug resistance.

Authors:  K D Tew
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

10.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

Authors:  S P Cole; G Bhardwaj; J H Gerlach; J E Mackie; C E Grant; K C Almquist; A J Stewart; E U Kurz; A M Duncan; R G Deeley
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

View more
  1 in total

1.  Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.

Authors:  Juan Du; Hui-Rong Shi; Fang Ren; Jing-Lu Wang; Qing-Hua Wu; Xia Li; Rui-Tao Zhang
Journal:  BMC Cancer       Date:  2017-12-14       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.